Valvular heart disease and the use of dopamine agonists for Parkinson's disease by Zanettini Renzo, Antonini Angelo, Gatto Gemma, Gentile Rosa, Tesei Silvana, Pezzoli Gianni in The New England journal of medicine (2007). PubMed

Abstract

Ergot-derived dopamine receptor agonists, often used in the treatment of Parkinson's disease, have been associated with an increased risk of valvular heart disease.

[ hide abstract ]

Discussed In Paper